MARKET

APOP

APOP

Cellect Bio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.300
-0.070
-2.08%
Closed 16:00 08/07 EDT
OPEN
3.350
PREV CLOSE
3.370
HIGH
3.350
LOW
3.210
VOLUME
82.78K
TURNOVER
--
52 WEEK HIGH
6.89
52 WEEK LOW
0.4000
MARKET CAP
11.14M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average APOP stock price target is 12.00 with a high estimate of 12.00 and a low estimate of 12.00.

EPS

APOP News

More
Cellect Bio nabs new patent in Europe
European Patent Office has granted Cellect Biotechnology (APOP +3.6%) a Patent Application no. 14851547.1 for Apograft, covering the activation of the stem
seekingalpha · 1d ago
European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation
Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has significantly strengthened its Intellectual Property (IP) portfolio as European Patent Application
PR Newswire · 1d ago
Cellect Biotechnology Q1 EPS $(0.002) Up From $(0.008) YoY
Cellect Biotechnology (NASDAQ:APOP) reported quarterly losses of $(0.00) per share. This is a 75 percent increase over losses of $(0.01) per share from the same period last year.
Benzinga · 05/21 20:19
84 Biggest Movers From Yesterday
Gainers
Benzinga · 05/13 09:31
60 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 05/12 16:26
Company News for May 12, 2020
Zacks · 05/12 15:09
Cellect Biotechnology Announces Exercise of Warrants for Cash Proceeds of Approximately $1.5 Million
GlobeNewswire · 05/12 13:48
GNFT, DT among premarket losers
Seeking Alpha - Article · 05/12 13:19

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
+0.08%

Hot Stocks

Symbol
Price
%Change

About APOP

Cellect Biotechnology Ltd is an Israel-based biotechnology company. Its technology platform, ApoGraft, selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies by using functional selection. Efficient selection enables retention of most of the stem cells while neutralizing harmful mature cells. ApoGraft exploit a functional characteristic of stem cells relating to apoptosis, which is the process of programmed cell death and is a vital part of physiological development and homeostasis of all organisms. Stem cells flourish in an environment where normal cells die because their main role is reconstitution of damaged tissue. The platform is being tested for clinical use in allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of hematological malignancies. Additionally, the Company is developing its first product based on its platform, the ApoTainer selection kit that utilizes FasL-coated paramagnetic beads.
More

Webull offers kinds of Cellect Biotechnology Ltd - ADR stock information, including NASDAQ:APOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APOP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APOP stock methods without spending real money on the virtual paper trading platform.